hiv-infections

Documents about hiv-infections

• Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women#889913ClinicalTrials.gov
• A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients#890696ClinicalTrials.gov
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy#909268ClinicalTrials.gov
• A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers#321541ClinicalTrials.gov
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults#411263ClinicalTrials.gov
• Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype#827810ClinicalTrials.gov
• Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV#846859ClinicalTrials.gov
• Pioglitazone to Treat Fatty Liver in People With HIV Infection#868834ClinicalTrials.gov
• A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)#902000ClinicalTrials.gov
• T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs#894010ClinicalTrials.gov
• Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men#226352ClinicalTrials.gov
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth#899815ClinicalTrials.gov
• Accelerating the development of affordable HIV drug resistance testing for use in low-and middle-income settings: report of a virtual meeting, 27 January 2025#155915WHO IRIS
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs#838354ClinicalTrials.gov
• A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#898005ClinicalTrials.gov
• Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults#162551ClinicalTrials.gov
• Reactogenicity and Immunogenicity of Vaginal CNgp140#195390ClinicalTrials.gov
• Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®#806789ClinicalTrials.gov
• Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)#858757ClinicalTrials.gov
• Retention in PrEP Care for African American MSM in Mississippi#908523ClinicalTrials.gov
• Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)#900053ClinicalTrials.gov
• Barriers and facilitators to linkage to HIV care after hospital discharge among adults living with advanced HIV disease in Uganda: a COM-B-guided qualitative study.#400702PubMed
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy#836600ClinicalTrials.gov
• Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients#837728ClinicalTrials.gov
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV#840991ClinicalTrials.gov
• Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)#849783ClinicalTrials.gov
• A Study of HIV Levels During Pregnancy and After Childbirth#873774ClinicalTrials.gov
• HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)#909400ClinicalTrials.gov
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs#828540ClinicalTrials.gov
• A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients#825782ClinicalTrials.gov
• A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir#837945ClinicalTrials.gov
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients#886982ClinicalTrials.gov
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV#905469ClinicalTrials.gov
• Framework for monitoring sexually transmitted infections and strengthening surveillance#286822WHO IRIS
• Directives pour la surveillance du VIH chez les malades tuberculeux#390525WHO IRIS
• Navigating viral load information flow and provider decision-making for adolescent clients at HIV clinics in Kenya.#9871PubMed
• Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria#123490ClinicalTrials.gov
• Structures of survival: Syndemic pathways to care among people with HIV involved with the criminal legal system.#157976PubMed
• Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections#245447ClinicalTrials.gov
• The impact of HIV coinfection on mpox patients: a systematic review and meta-analysis#642278Europe PMC
• Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia#651799Europe PMC
• The Role of Atherosclerosis in HIV-Related Stroke in South Africa#673184WIReDSpace
• Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort#806170ClinicalTrials.gov
• Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density#807324ClinicalTrials.gov
• SHARE: Simple HAART With Abacavir, Reyataz, and Epivir#845713ClinicalTrials.gov
• Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS#858878ClinicalTrials.gov
• Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence#872399ClinicalTrials.gov
• Long-term Follow-up of HIV Infected Patients Identified During Early Infection#875520ClinicalTrials.gov
• Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients#876190ClinicalTrials.gov
• Directly Observed Therapy for HIV Infected Adolescents#885924ClinicalTrials.gov